Neurology News

A Swiss-based medical technology company has announced a partnership with Biogen to advance a digital biomarker platform involved in a planned clinical trial for BIIB122, a novel therapeutic to treat Parkinson’s disease.

The number one financial goal for most physicians is getting to a comfortable retirement on their own timeline and with the lifestyle they want.

A United Kingdom-based clinical-stage biotech company has announced commencement of a first-in-human clinical trial of a selective central nervous system-penetrant compound to treat Parkinson’s disease.

Treatment with atogepant 60mg once daily significantly reduced monthly migraine days at 12 weeks compared with oral rimegepant 75mg every other day, according to research published in Cephalalgia.

Compared with oral administration, continuous subcutaneous infusion of carbidopa/levodopa was linked to nearly 2 more hours of “on” time without dyskinesia in adults with Parkinson’s disease, data from The Lancet Neurology show.

According to published results, industry payment distributions may be skewed by the 0.1% of physicians in each specialty who were paid more than $1 million from 2013 to 2022.

The FDA has granted clearance to a transcranial magnetic stimulation device as an adjunctive treatment for major depressive disorder in patients aged 15 to 21 years, according to the manufacturer.

A novel bivalent-targeting, intrathecally delivered chimeric antigen receptor T-cell therapy decreased tumor size in patients with recurrent glioblastoma, according to results from a phase 1 study published in Nature Medicine.

WEST PALM BEACH, Fla. — Spatial mapping of lesional tissue is a precise method to identify key functional interactions that may lead to successful therapeutic intervention in multiple sclerosis, according to a presenter at ACTRIMS 2024.

Environmental injustices such as air pollution and poor transport infrastructure may play a significant role in regional risk for cardiovascular disease and risk factors for it, researchers reported.